MCL1 and cancer: Interestingly, an independent study aiming at elucidating the molecular basis of immune resistance in cancer cells showed that NANOG-mediated/HDAC1-driven epigenetic silencing of TRIM17 resulted in stabilization of MCL1 and subsequent resistance to apoptosis in immune-edited tumor cells [22].